MHRA extend fee waiver programme for UK micro and small enterprises Membership NewsMembership News Archive

MHRA extend fee waiver programme for UK micro and small enterprises

The MHRA have extended their fee waiver programme for UK micro and small enterprises developing innovative medical devices. The updated programme will run from 20 April 2026 to 5 April 2027, following evaluation of the initial pilot. Based on feedback, they have introduced two key changes: The programme now includes some Class III medical devices The MHRA will now review…
Ben Kemp
April 28, 2026
Institute of Directors Health and Life Sciences Special Interest Group launch event – 6th May Membership NewsMembership News Archive

Institute of Directors Health and Life Sciences Special Interest Group launch event – 6th May

The Institute of Directors (IoD) is bringing together leaders from across the Health & Life Sciences sector to launch their newest Special Interest Group. 📅 6 May 2026 ⌚ 6:30–8:30pm 📍 Cafe Duke, 116 Pall Mall George Freeman MP, Dr Annalisa Jenkins OBE, and Chris Molloy will feature as guest speakers, and attendees will have the opportunity to connect with…
Ben Kemp
April 28, 2026
Ben visits Parliament for Health and Life Sciences Showcase event Membership NewsMembership News Archive

Ben visits Parliament for Health and Life Sciences Showcase event

BIVDA's Policy and Public Affairs Executive Ben Kemp attended a Health and Life Sciences Showcase event in Parliament hosted by Curia, UKAI and UKHLSI. The event sought to highlight health companies with highly innovative products, including BIVDA member Genomics. It was attended by innovators, NHS leaders, and parliamentarians, the latter including sponsoring MP Steve Yemm and former Chair of the…
Ben Kemp
April 28, 2026
BIVDA welcomes £237 million funding announcement for Community Diagnostic Centres HighlightsHighlights Archive

BIVDA welcomes £237 million funding announcement for Community Diagnostic Centres

BIVDA welcomes the announcement of £237 million in funding for Community Diagnostic Centres (CDCs) across England. This will facilitate the opening of four new CDCs as well as the expansion and enhancement of 32 existing facilities. In 2025, helped by the work of CDCs, the NHS in England carried out a record number of important diagnostic tests - almost 30…
Ben Kemp
April 28, 2026
Value-based procurement (VBP) assessment methodology set for June release HighlightsHighlights Archive

Value-based procurement (VBP) assessment methodology set for June release

The Department of Health and Social Care (DHSC) is preparing to introduce its new value-based procurement (VBP) framework in June, remaining on schedule for rollout. Senior figures are set to promote the initiative at major industry gatherings during that month. David Lawson, who leads the DHSC’s Medical Technology and Innovation Directorate, will outline the methodology at Med-Tech Expo in Birmingham…
Ben Kemp
April 28, 2026
Helen pens NHS innovation article for Chamber UK journal Membership NewsMembership News Archive

Helen pens NHS innovation article for Chamber UK journal

BIVDA Chief Executive Helen Dent has had her article, 'Pass the Baton: Why NHS Innovation Stalls at the Finish Line', published in Chamber UK journal, read by parliamentarians across both Houses. In the article, Helen observed that, despite widespread agreement across industry, the NHS and government on what needs to change, progress remains limited. She noted that while experts have…
Ben Kemp
April 28, 2026
BIVDA hosts DBT/OLS India Free Trade Agreement Life Sciences Roundtable Membership NewsMembership News Archive

BIVDA hosts DBT/OLS India Free Trade Agreement Life Sciences Roundtable

BIVDA was pleased to host the Department of Business and Trade (DBT) and Office for Life Sciences (OLS) last week as they presented on what the UK-India Free Trade Agreement (FTA) means for life sciences companies. Set to take effect in early July, the FTA will open up UK businesses to £38bn in Indian public procurement. Of particular interest to…
Ben Kemp
April 28, 2026
BIVDA Webinar: From Snapshot to Stream: How Continuous Health Data May Reshape Diagnostics Membership NewsMembership News Archive

BIVDA Webinar: From Snapshot to Stream: How Continuous Health Data May Reshape Diagnostics

Date and time: Tuesday 12th May 2026 at 2pm - 3pm Traditional IVDs provide high-quality diagnostic snapshots. However, healthcare delivery is increasingly moving toward continuous, remote, and prevention-driven models. This session explores how longitudinal wearable data and digital biomarkers may complement in vitro diagnostics, and what this shift means for product design, clinical evidence, regulatory pathways, and NHS integration. This…
Ben Kemp
April 27, 2026
Helen meets with Health Committee Chair Layla Moran MP Membership NewsMembership News Archive

Helen meets with Health Committee Chair Layla Moran MP

Last week, BIVDA Chief Executive Helen Dent met with Chair of the Health and Social Care Committee Layla Moran MP during a roundtable on the future of UK health policy. Despite the Government identifying our sector as critical to economic growth and global biosecurity, Helen highlighted that companies continue to face significant barriers to NHS adoption – driven by short-term…
Ben Kemp
April 27, 2026
Government currently exceeding its 150-day clinical trial target HighlightsHighlights Archive

Government currently exceeding its 150-day clinical trial target

The UK is on track to surpass its target of reducing commercial clinical trial set-up times to 150 days, with new data showing timelines have fallen to an average of 122 days — down from 169 days over the same period last year. Backed by over £137 million in investment, the improvements reflect expanded research infrastructure, increased trial set-up capacity,…
Ben Kemp
April 27, 2026